Biota's re-rating is already in the pipeline.
Taylor Collison have a valuation of $1.80 from 12 June 2009, however, this was based on royalties of only $32m for Relenza in 2010.
Taylor Collison's report:
http://www.biota.com.au/uploaded/154/1021525_25taylorcollisonbta0906-h.pdf
A new valuation based on greatly increased sales of Relenza will see the target price far exceed $3.
- Forums
- ASX - By Stock
- BTA
- $3-$5 when analyst's recalculate estimates
$3-$5 when analyst's recalculate estimates
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)